Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan

Fumiaki Ueno, Toshiyuki Matsui, Takayuki Matsumoto, Katsuyoshi Matsuoka, Mamoru Watanabe, Toshifumi Hibi

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Crohn's disease is a disorder of unknown etiology and complicated pathogenesis. A substantial amount of evidence has accumulated recently and has been applied to clinical practice. The present guidelines were developed based on recent evidence and the formal consensus of experts relevant to this disease. Here we provide an overview of these guidelines, as follows. Target disease: Crohn's disease Users: Clinical practitioners in internal medicine, surgery, gastroenterology, and general practice Purpose: To provide appropriate clinical indicators to practitioners Scope of clinical indicators: Concept of Crohn's disease, epidemiology, classifications, diagnosis, treatment, follow up, and special situations Intervention: Diagnosis (interview, physical examination, clinical laboratory tests, imaging, and pathology) and treatment (lifestyle guidance, drug therapy, nutritional therapy, surgery, etc.) Outcome assessment: Attenuation of symptoms, induction and maintenance of remission, imaging findings, quality of life (QOL), prevention of complications and harm of therapy Methods for developing these guidelines: Described in the text Basis of recommendations: Integration of evidence level and consensus of experts Cost-benefit analysis: Not implemented Evaluation of effectiveness: Yet to be confirmed Status of guidelines: Updated version of the first Guidelines published in 2010 Publication sources: Printed publication available and electronic information in preparation Patient information: Not available Date of publication: October 2011 These guidelines were intended primarily to be used by practitioners in Japan, and the goal of these guidelines is to improve the outcomes of patients with Crohn's disease.

Original languageEnglish
Pages (from-to)31-72
Number of pages42
JournalJournal of Gastroenterology
Volume48
Issue number1
DOIs
Publication statusPublished - 2013 Jan

Fingerprint

Evidence-Based Practice
Practice Guidelines
Crohn Disease
Consensus
Japan
Guidelines
Publications
Remission Induction
Gastroenterology
Therapeutics
Internal Medicine
General Practice
Physical Examination
Cost-Benefit Analysis
Life Style
Epidemiology
Maintenance
Quality of Life
Outcome Assessment (Health Care)
Interviews

Keywords

  • Consensus
  • Crohn's disease
  • Evidence
  • Guidelines
  • Practice guidelines

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan. / Ueno, Fumiaki; Matsui, Toshiyuki; Matsumoto, Takayuki; Matsuoka, Katsuyoshi; Watanabe, Mamoru; Hibi, Toshifumi.

In: Journal of Gastroenterology, Vol. 48, No. 1, 01.2013, p. 31-72.

Research output: Contribution to journalArticle

Ueno, Fumiaki ; Matsui, Toshiyuki ; Matsumoto, Takayuki ; Matsuoka, Katsuyoshi ; Watanabe, Mamoru ; Hibi, Toshifumi. / Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan. In: Journal of Gastroenterology. 2013 ; Vol. 48, No. 1. pp. 31-72.
@article{19fa8fafee544447ae86ad8b43f14247,
title = "Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan",
abstract = "Crohn's disease is a disorder of unknown etiology and complicated pathogenesis. A substantial amount of evidence has accumulated recently and has been applied to clinical practice. The present guidelines were developed based on recent evidence and the formal consensus of experts relevant to this disease. Here we provide an overview of these guidelines, as follows. Target disease: Crohn's disease Users: Clinical practitioners in internal medicine, surgery, gastroenterology, and general practice Purpose: To provide appropriate clinical indicators to practitioners Scope of clinical indicators: Concept of Crohn's disease, epidemiology, classifications, diagnosis, treatment, follow up, and special situations Intervention: Diagnosis (interview, physical examination, clinical laboratory tests, imaging, and pathology) and treatment (lifestyle guidance, drug therapy, nutritional therapy, surgery, etc.) Outcome assessment: Attenuation of symptoms, induction and maintenance of remission, imaging findings, quality of life (QOL), prevention of complications and harm of therapy Methods for developing these guidelines: Described in the text Basis of recommendations: Integration of evidence level and consensus of experts Cost-benefit analysis: Not implemented Evaluation of effectiveness: Yet to be confirmed Status of guidelines: Updated version of the first Guidelines published in 2010 Publication sources: Printed publication available and electronic information in preparation Patient information: Not available Date of publication: October 2011 These guidelines were intended primarily to be used by practitioners in Japan, and the goal of these guidelines is to improve the outcomes of patients with Crohn's disease.",
keywords = "Consensus, Crohn's disease, Evidence, Guidelines, Practice guidelines",
author = "Fumiaki Ueno and Toshiyuki Matsui and Takayuki Matsumoto and Katsuyoshi Matsuoka and Mamoru Watanabe and Toshifumi Hibi",
year = "2013",
month = "1",
doi = "10.1007/s00535-012-0673-1",
language = "English",
volume = "48",
pages = "31--72",
journal = "Journal of Gastroenterology",
issn = "0944-1174",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan

AU - Ueno, Fumiaki

AU - Matsui, Toshiyuki

AU - Matsumoto, Takayuki

AU - Matsuoka, Katsuyoshi

AU - Watanabe, Mamoru

AU - Hibi, Toshifumi

PY - 2013/1

Y1 - 2013/1

N2 - Crohn's disease is a disorder of unknown etiology and complicated pathogenesis. A substantial amount of evidence has accumulated recently and has been applied to clinical practice. The present guidelines were developed based on recent evidence and the formal consensus of experts relevant to this disease. Here we provide an overview of these guidelines, as follows. Target disease: Crohn's disease Users: Clinical practitioners in internal medicine, surgery, gastroenterology, and general practice Purpose: To provide appropriate clinical indicators to practitioners Scope of clinical indicators: Concept of Crohn's disease, epidemiology, classifications, diagnosis, treatment, follow up, and special situations Intervention: Diagnosis (interview, physical examination, clinical laboratory tests, imaging, and pathology) and treatment (lifestyle guidance, drug therapy, nutritional therapy, surgery, etc.) Outcome assessment: Attenuation of symptoms, induction and maintenance of remission, imaging findings, quality of life (QOL), prevention of complications and harm of therapy Methods for developing these guidelines: Described in the text Basis of recommendations: Integration of evidence level and consensus of experts Cost-benefit analysis: Not implemented Evaluation of effectiveness: Yet to be confirmed Status of guidelines: Updated version of the first Guidelines published in 2010 Publication sources: Printed publication available and electronic information in preparation Patient information: Not available Date of publication: October 2011 These guidelines were intended primarily to be used by practitioners in Japan, and the goal of these guidelines is to improve the outcomes of patients with Crohn's disease.

AB - Crohn's disease is a disorder of unknown etiology and complicated pathogenesis. A substantial amount of evidence has accumulated recently and has been applied to clinical practice. The present guidelines were developed based on recent evidence and the formal consensus of experts relevant to this disease. Here we provide an overview of these guidelines, as follows. Target disease: Crohn's disease Users: Clinical practitioners in internal medicine, surgery, gastroenterology, and general practice Purpose: To provide appropriate clinical indicators to practitioners Scope of clinical indicators: Concept of Crohn's disease, epidemiology, classifications, diagnosis, treatment, follow up, and special situations Intervention: Diagnosis (interview, physical examination, clinical laboratory tests, imaging, and pathology) and treatment (lifestyle guidance, drug therapy, nutritional therapy, surgery, etc.) Outcome assessment: Attenuation of symptoms, induction and maintenance of remission, imaging findings, quality of life (QOL), prevention of complications and harm of therapy Methods for developing these guidelines: Described in the text Basis of recommendations: Integration of evidence level and consensus of experts Cost-benefit analysis: Not implemented Evaluation of effectiveness: Yet to be confirmed Status of guidelines: Updated version of the first Guidelines published in 2010 Publication sources: Printed publication available and electronic information in preparation Patient information: Not available Date of publication: October 2011 These guidelines were intended primarily to be used by practitioners in Japan, and the goal of these guidelines is to improve the outcomes of patients with Crohn's disease.

KW - Consensus

KW - Crohn's disease

KW - Evidence

KW - Guidelines

KW - Practice guidelines

UR - http://www.scopus.com/inward/record.url?scp=84872494692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872494692&partnerID=8YFLogxK

U2 - 10.1007/s00535-012-0673-1

DO - 10.1007/s00535-012-0673-1

M3 - Article

VL - 48

SP - 31

EP - 72

JO - Journal of Gastroenterology

JF - Journal of Gastroenterology

SN - 0944-1174

IS - 1

ER -